Description
Vildagliptin 50mg + Metformin SR 1000mg
Used in Newly Diagnosed T2DM Patients
Combination provides dual, complementary mechanisms—Metformin reduces hepatic glucose output & insulin resistance, while Vildagliptin enhances incretin action to boost insulin and suppress glucagon—resulting in comprehensive glycemic control, excellent tolerability, weight neutrality, and long-term β-cell protection.
Dosage: Available in oral tablet form. Once Daily
